期刊文献+

GPR30在子宫平滑肌瘤发病机制中的研究进展 被引量:4

Research Progress of G Protein-Coupled Receptor 30 in the Pathogenesis of Uterine Leiomyoma
下载PDF
导出
摘要 子宫平滑肌瘤是女性生殖系统常见的良性肿瘤,其特征是平滑肌细胞的增殖,子宫多发肌瘤和特殊部位的肌瘤给女性的健康带来很大影响,严重影响其生活质量。尽管其病因和发病机制尚未明确,但一般认为它与雌激素的刺激密切相关,并涉及肌瘤细胞生理病理等机制。随着对雌激素作用的深入研究,一种新型雌激素受体—7次跨膜G蛋白偶联雌激素受体,其介导雌激素通过快速效应途径使靶细胞增殖,在子宫平滑肌瘤发生发展中发挥重要作用。 Uterine leiomyoma is a common benign tumor of the female reproductive system, which is characterized by smooth muscle cell proliferation. Multiple uterine fibroids and special location bring a great impact to female health, seriously affecting the quality of their life. Although the etiology and pathogenesis of uterine leiomyoma is unclear, it is generally believed to be closely related to estrogen stimulation and involves the physiological and pathological mechanisms of myoma cells. Recently, with the deepening of the study of the role of estrogen, a novel estrogen receptor-7-transmembrane G protein-coupled receptor emerges ,which mediates estrogen through the rapid effect pathway to proliferate the target cells and plays an important role in the development of uterine leiomyoma.
出处 《医学综述》 2017年第11期2140-2144,2149,共6页 Medical Recapitulate
关键词 子宫平滑肌瘤 雌激素 G蛋白偶联受体30 信号通路 Leiomyoma Estrogen G protein-coupled receptor 30 Signal pathway
  • 相关文献

参考文献5

二级参考文献38

  • 1Bergman L, Beelen MLR, Gallee MPW, et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer[J]. Lan- cet ,2000,356 ( 9233 ) :881-887. 被引量:1
  • 2Killaekey MA, Hakes TB, Pierce VK. Endnmetrial adenoearcino- ma in breast cancer patients receiving antiestrogens [ J ]. Cancer Treat Rep, 1985,69 ( 2 ) :237-238. 被引量:1
  • 3ACOG committee opinion. No. 336 : Tamoxifen and uterine cancer [ J ]. Obstet Gyneco1,2006,107 ( 6 ) : 1475-1478. 被引量:1
  • 4Creutzberg CL, van Putten WLJ, Koper PCM, etal. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometfial carcinoma: multieentre randomized trial [ J]. Lancet,2000,355 ( 9213 ) : 1404-1411. 被引量:1
  • 5Mundt A J, Waggoner S, Yamada D, et al. Age as a prognostic factor for recurrence in patients with endometrial carcinoma [ J ]. Gynecol 0neol,2000,79 ( 1 ) :79-85. 被引量:1
  • 6Bernstein L, Deapen D, Cerhan JR, et al. Tamoxifen therapy for breast cancer and endom etrial cancer risk[J]. J Natl Cancer Inst, 1999,91 (19) : 1654-1662. 被引量:1
  • 7Taylor SG, Gelman RS, Falkson G, et al. Combination chemother- apy compm'ed to tamoxifen as initial therapy for stage 1V breast cancer in elderly women [ J ]. Ann Intern Med, 1986,104 (4) : 455-461. 被引量:1
  • 8Magriples U, Naftolin F, Schwartz PE, et al. High-grade endome- trial carcinoma in tamoxifen-treated breast cancer patients[J]. J Clin Onco1,1993,11 (3) :486. 被引量:1
  • 9江泽飞 宋三泰.早期乳腺癌辅助内分泌治疗的基本原则和新进展.内分泌外科,2006,5(4):3-3. 被引量:1
  • 10Menter DG, Dubois RN. Prostaglandins in cancer cell adhe- sion, migration, and invasion. Int J Cell Biol, 2012, 2012: 723419. 被引量:1

共引文献19

同被引文献43

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部